KRAS G12C Mutations
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies (NCT07542704) | Kumquat Biosciences Inc. | 2026-05-01 |
| A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations (NCT06412198) | M.D. Anderson Cancer Center | 2024-08-28 |
Track KRAS G12C Mutations automatically
Every clearance here is in the API, with alerts when new ones post.